scholarly journals PPARG2 Pro12Ala polymorphism influences body composition changes in severely obese patients consuming extra virgin olive oil: a randomized clinical trial

2018 ◽  
Vol 15 (1) ◽  
Author(s):  
Ana Paula Santos Rodrigues ◽  
Lorena Pereira Souza Rosa ◽  
Erika Aparecida Silveira
Author(s):  
Carolina Rodrigues Mendonça ◽  
Matias Noll ◽  
Camila Kellen de Souza Cardoso ◽  
Annelisa Silva Alves de Carvalho Santos ◽  
Ana Paula dos Santos Rodrigues ◽  
...  

The objective of this study was to analyze the effectiveness of two nonpharmacological interventions—traditional Brazilian diet (DieTBra), and extra-virgin olive oil (EVOO)—in terms of the reduction in pain and pain intensity in individuals with severe obesity. We conducted a 12-week parallel randomized clinical trial with 149 individuals (body mass index (BMI) ≥ 35 kg/m2) who were randomized into three groups: supplementation with EVOO (n = 50), DieTBra (n = 49), and EVOO + DieTBra (n = 50). Of the total, 133 individuals with a mean BMI of 46.04 kg/m2 completed the study. By the end of the follow-up, there was a reduction in severe pain in the EVOO + DieTBra group (p = 0.003). There was a significant reduction in severe pain in the EVOO + DieTBra group (−22.7%); pain in the wrist and hand (−14.1%), upper back (−26.9%), and knees (−18.4%) in the DieTBra group; and reduction in hip pain (−11.1%) with EVOO consumption. We conclude that EVOO and DieTBra, either alone or in combination, are effective interventions to reduce pain intensity and pain in different regions in individuals with severe obesity, and have great potential for clinical application.


2017 ◽  
Vol 57 (7) ◽  
pp. 2445-2455 ◽  
Author(s):  
Flávia Galvão Cândido ◽  
Flávia Xavier Valente ◽  
Laís Emilia da Silva ◽  
Olívia Gonçalves Leão Coelho ◽  
Maria do Carmo Gouveia Peluzio ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Anna Boronat ◽  
Natalia Soldevila-Domenech ◽  
Julián Andrés Mateus ◽  
Patrícia Díaz ◽  
Marta Pérez ◽  
...  

Abstract Objectives Hydroxytyrosol (HT) has been associated to health beneficial effects of extra virgin olive oil. Red wine is an indirect source of HT as it contains its precursor tyrosol (TYR), which is endogenously converted into HT. Beer is another source of TYR, which is originated during the fermentation as a secondary a metabolite of the amino acid tyrosine. The present work shows the first clinical study aimed at assessing the endogenous formation of HT following beer consumption. Methods Cross-over randomized clinical trial in healthy volunteers administered 250 mL of a dark beer (3.5 mg of TYR and 17.0 g alcohol), 250 mL of a lager beer (2.3 mg of TYR and 9.0 g alcohol), 250 mL of a non-alcoholic beer (1.4 mg of TYR and 0 g alcohol), and finally 150 mL of red wine (3.7 mg of TYR and 16.8 g alcohol). Urinary recovery of TYR and HT metabolites was quantified by LC/MS-MS. Results Results confirm that TYR present in beer is absorbed and endogenously converted into HT after its consumption (Figure 1). Nevertheless, the highest recovery was observed after red wine. Dark beer administration, which TYR and alcohol doses were equal to red wine, presented lower levels of TYR absorbed and hence, lower levels of HT generated. Lager and non-alcoholic beer presented dose-response absorption of TYR, but not an HT generation. Conclusions The present study is the first demonstrating that TYR present in beer is absorbed and endogenously biotransformed into HT in humans. HT generation is not TYR and alcohol dose-dependent and, is globally lower than following red wine, suggesting that other factors such as gas or other phenols could interfere in TYR bioavailability. Interestingly, HT recoveries after non-alcoholic beer are similar to those observed after alcoholic ones, limiting alcohol intake and the health and social problems associated to alcohol abuse. These findings could be relevant to understand the health effects associated to beer consumption. Funding Sources AB is recipient of a fellowship from ISCIII (PFIS), NS is recipient of a fellowship from Centro de Información Cerveza y Salud (Beca Manuel Oya) and CIBEROBN. Supporting Tables, Images and/or Graphs


2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Ana Paula dos Santos Rodrigues ◽  
Lorena Pereira Souza Rosa ◽  
Hugo Delleon da Silva ◽  
Elisângela de Paula Silveira-Lacerda ◽  
Erika Aparecida Silveira

Background. ThePPARG2Pro12Ala (rs1801282) andIL6-174G >C (rs1800795) have important function in body weight regulation and a potential role in obesity risk. We aimed to investigate the association betweenPPARG2Pro12Ala andIL6-174G >C variants and the genotypes interaction with body composition, metabolic markers, food consumption, and physical activity in severely obese patients.Methods. 150 severely obese patients (body mass index (BMI) ≥ 35 kg/m2) from Central Brazil were recruited. Body composition, metabolic parameters, physical activity, and dietary intake were measured. The genotype was determined by the qPCR TaqMan Assays System. Multiple linear regression and multiple logistic regression models were fitted adjusting for confounders.Results. Ala carriers of the Pro12Ala polymorphism had higher adiposity measures (BMI:p=0.031, and fat mass:p=0.049) and systolic blood pressure (p=0.026) compared to Pro homozygotes. We found no important associations between the -174G >C polymorphism and obesity phenotypes. When genotypes were combined, individuals with genotypes ProAla + AlaAla and GC + CC presented higher BMI (p=0.029) and higher polyunsaturated fatty acids (PUFAs) consumption (p=0.045) compared to the ones with genotypes ProPro and GG, and individuals carriers of thePPARG2Ala allele only (genotype ProAla + AlaAla and GG) had higher fat mass and systolic and diastolic blood pressure compared to the ones with genotypes ProPro and GG.Conclusions. Severely obese individuals carrying the Ala allele of thePPARG2Pro12Ala polymorphism had higher measures of adiposity and blood pressure, while no important associations were found for theIL6-174G >C polymorphism.


Nutrients ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 1413 ◽  
Author(s):  
Annelisa Silva e Alves de Carvalho Santos ◽  
Ana Paula dos Santos Rodrigues ◽  
Lorena Pereira de Souza Rosa ◽  
Matias Noll ◽  
Erika Aparecida Silveira

Cardioprotective effects associated with extra virgin olive oil (EVOO) have been studied within the Mediterranean diet. However, little is known about its consumption in the traditional Brazilian diet (DieTBra) or without any dietary prescription, particularly in severely obese individuals. This study aimed to assess the effectiveness of DieTBra and EVOO in cardiometabolic risk factor (CMRF) reduction in severely obese individuals. We conducted a parallel randomized clinical trial with 149 severely obese individuals (body mass index ≥ 35.0 kg/m2) aged 18–65 years, assigned to three groups: 52 mL/day of EVOO (n = 50), DieTBra (n = 49), and DieTBra + 52 mL/day of EVOO (n = 50). Participants were followed up for 12 weeks. Low-density lipoprotein cholesterol (LDL-c) was the primary endpoint and several cardiometabolic parameters were secondary endpoints. Endpoints were compared at baseline and at the end of the study using analysis of variance, the Kruskal–Wallis test, and Student’s t-test. The TC/High-density lipoprotein (HDL) ratio (−0.33 ± 0.68, p = 0.002) and LDL/HDL ratio (−0.26 ± 0.59, p = 0.005) decreased in the EVOO group. Delta values for all variables showed no significant statistical difference between groups. However, we highlight the clinical significance of LDL-c reduction in the EVOO group by 5.11 ± 21.79 mg/dL and in the DieTBra group by 4.27 ± 23.84 mg/dL. We also found a mean reduction of around 10% for Castelli II (LDL/HDL) and homocysteine in the EVOO group and TG and the TG/HDL ratio in the DieTBra group. EVOO or DieTBra when administered alone lead to reduction in some cardiometabolic risk parameters in severely obese individuals.


2020 ◽  
Author(s):  
Nafiseh Khandouzi ◽  
Ali Zahedmehr ◽  
Javad Nasrollahzadeh

Abstract Background Olive oil, rich in mono-unsaturated fatty acid and the main fat in the Mediterranean diet, has long been considered to be favorable for cardiovascular health. The present study was conducted to compare the effects of high polyphenol extra-virgin olive oil (EVOO) with low polyphenol refined olive oil (ROO) on some cardiovascular risk factors in patients undergoing coronary angiography. Methods In a randomized, controlled, parallel-arm, clinical trial, 40 patients (aged 54.83 ± 7.04 years) with at least one classic cardiovascular risk factor (hypertension, dyslipidemia, or diabetes) who referred to coronary angiography were randomly allocated to two groups and received 25 mL EVOO (n = 20) or ROO (n = 20) daily for 6 weeks. Fasting blood was collected and plasma lipids, malondialdehyde (MDA), C-reactive protein (CRP) as well as, inflammatory cytokines in ex-vivo lipopolysaccharide (LPS)-stimulated whole blood culture were measured at the baseline and after the dietary intervention. Results Baseline characteristics were similar between the two groups. Plasma LDL-cholesterol significantly reduced in EVOO group (-9.52 ± 20.44 vs 8.68 ± 18.77 mg/dL, p = 0.007 for EVOO and ROO respectively), whereas total cholesterol/HDL-cholesterol had no significant changes. EVOO resulted in significant reduction in plasma CRP (-0.40 ± 0.52 vs 0.007 ± 0.42 mg/L, p = 0.01 for EVOO and ROO respectively) and increased ex-vivo whole blood LPS-stimulated IL-10 production (12.13 ± 33.64 vs -17.47 ± 49.04 pg/mL, p = 0.035 for EVOO and ROO respectively). However, there were no significant differences in LPS-stimulated IL-6 and plasma MDA levels between the two groups. Conclusions Daily consumption of polyphenol-rich EVOO in subjects who have been under medical treatment with risk-reducing agents could additionally improve LDL-C and selected inflammatory markers. Trial registration: NCT03796780 at clinicaltrial.gov (12/29/2018)


Sign in / Sign up

Export Citation Format

Share Document